Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
2 reports, 2 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biovie submitted trial data to the U.S. Food and Drug Administration and announced results from its offices in Carson City, Nev.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
- FDA
-
Nasdaq
American fully electronic stock exchange
Related events
- Cuong Do leads BioVie as its CEO. BioVie Inc is listed on the NASDAQ exchange and is seeking FDA review for its drug candidate.
- Argenx SE announced it is listed on Nasdaq and is seeking FDA priority review and approval.
- FDA approval supports NDA submission in Aurora.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.